NATCO Pharma Limited (NATCOPHARM.NS)
INR 775.5
(3.88%)
INR 775.5
(3.88%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 25.96 Billion INR | 78.53% |
| 2022 | 8.76 Billion INR | 298.54% |
| 2021 | 2.19 Billion INR | -56.11% |
| 2020 | 5.01 Billion INR | 2.0% |
| 2019 | 4.91 Billion INR | -31.59% |
| 2018 | 7.18 Billion INR | -17.99% |
| 2017 | 8.75 Billion INR | 33.56% |
| 2016 | 6.55 Billion INR | 177.42% |
| 2015 | 2.36 Billion INR | 38.37% |
| 2014 | 1.7 Billion INR | 13.4% |
| 2013 | 1.5 Billion INR | 14.15% |
| 2012 | 1.31 Billion INR | 40.71% |
| 2011 | 937.55 Million INR | 4.98% |
| 2010 | 893.11 Million INR | 4.08% |
| 2009 | 858.06 Million INR | 12.76% |
| 2008 | 760.95 Million INR | 14.6% |
| 2007 | 664.02 Million INR | 31.94% |
| 2006 | 503.26 Million INR | 110.65% |
| 2005 | 238.91 Million INR | -24.62% |
| 2004 | 316.94 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 FY | 15.64 Billion INR | 78.53% |
| 2023 Q4 | 7.6 Billion INR | 72.18% |
| 2023 Q1 | 4.43 Billion INR | -11.98% |
| 2023 Q2 | 2.6 Billion INR | -41.21% |
| 2023 Q3 | 4.41 Billion INR | 69.34% |
| 2022 Q3 | 3.27 Billion INR | 283.92% |
| 2022 Q1 | 741 Million INR | -81.0% |
| 2022 Q4 | 5.04 Billion INR | 54.14% |
| 2022 FY | 8.76 Billion INR | 298.54% |
| 2022 Q2 | 852 Million INR | 14.98% |
| 2021 Q3 | -474 Million INR | -149.38% |
| 2021 FY | 2.19 Billion INR | -56.11% |
| 2021 Q1 | 358 Million INR | -52.89% |
| 2021 Q2 | 960 Million INR | 168.16% |
| 2021 Q4 | 3.9 Billion INR | 922.78% |
| 2020 Q1 | 2.47 Billion INR | 73.1% |
| 2020 Q4 | 760 Million INR | 32.17% |
| 2020 Q3 | 575 Million INR | 9.11% |
| 2020 Q2 | 527 Million INR | -78.72% |
| 2020 FY | 5.01 Billion INR | 2.0% |
| 2019 Q4 | 1.43 Billion INR | 34.75% |
| 2019 FY | 4.91 Billion INR | -31.59% |
| 2019 Q1 | 1.12 Billion INR | -33.61% |
| 2019 Q2 | 1.03 Billion INR | -8.1% |
| 2019 Q3 | 1.06 Billion INR | 2.81% |
| 2018 Q2 | 1.87 Billion INR | -6.29% |
| 2018 Q1 | 2 Billion INR | 0.55% |
| 2018 Q4 | 1.69 Billion INR | 29.43% |
| 2018 FY | 7.18 Billion INR | -17.99% |
| 2018 Q3 | 1.3 Billion INR | -30.31% |
| 2017 Q2 | 2.69 Billion INR | 154.3% |
| 2017 Q4 | 1.99 Billion INR | -45.47% |
| 2017 Q3 | 3.65 Billion INR | 35.65% |
| 2017 Q1 | 1.05 Billion INR | -12.98% |
| 2017 FY | 8.75 Billion INR | 33.56% |
| 2016 FY | 6.55 Billion INR | 177.42% |
| 2016 Q1 | 412.4 Million INR | -1.22% |
| 2016 Q2 | 2.16 Billion INR | 424.9% |
| 2016 Q4 | 1.21 Billion INR | -46.53% |
| 2016 Q3 | 2.27 Billion INR | 5.14% |
| 2015 Q3 | 809 Million INR | 100.3% |
| 2015 Q1 | 357.5 Million INR | -7.46% |
| 2015 Q4 | 417.5 Million INR | -48.39% |
| 2015 FY | 2.36 Billion INR | 38.37% |
| 2015 Q2 | 403.9 Million INR | 12.98% |
| 2014 Q2 | 315.3 Million INR | -22.53% |
| 2014 Q4 | 386.3 Million INR | -45.17% |
| 2014 Q3 | 704.49 Million INR | 123.44% |
| 2014 Q1 | 407 Million INR | 44.99% |
| 2014 FY | 1.7 Billion INR | 13.4% |
| 2013 Q2 | 303.1 Million INR | 39.81% |
| 2013 Q4 | 280.7 Million INR | -57.27% |
| 2013 FY | 1.5 Billion INR | 14.15% |
| 2013 Q1 | 216.8 Million INR | -34.1% |
| 2013 Q3 | 656.95 Million INR | 116.75% |
| 2012 FY | 1.31 Billion INR | 40.71% |
| 2012 Q3 | 519.49 Million INR | 107.8% |
| 2012 Q2 | 250 Million INR | -36.4% |
| 2012 Q1 | 393.1 Million INR | 96.94% |
| 2012 Q4 | 329 Million INR | -36.67% |
| 2011 FY | 937.55 Million INR | 4.98% |
| 2011 Q2 | 179.5 Million INR | -34.99% |
| 2011 Q3 | 401.25 Million INR | 123.54% |
| 2011 Q4 | 199.6 Million INR | -50.26% |
| 2011 Q1 | 276.1 Million INR | 0.0% |
| 2010 FY | 893.11 Million INR | 4.08% |
| 2009 FY | 858.06 Million INR | 12.76% |
| 2008 FY | 760.95 Million INR | 14.6% |
| 2007 FY | 664.02 Million INR | 31.94% |
| 2006 FY | 503.26 Million INR | 110.65% |
| 2005 FY | 238.91 Million INR | -24.62% |
| 2004 FY | 316.94 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | -350.878% |
| Hester Biosciences Limited | 364.77 Million INR | -7017.362% |
| Aarti Drugs Limited | 7.14 Billion INR | -263.17% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | -729.956% |
| Albert David Limited | 1.33 Billion INR | -1845.51% |
| Alembic Limited | 767.77 Million INR | -3281.481% |
| Alkem Laboratories Limited | 19.46 Billion INR | -33.399% |
| Bafna Pharmaceuticals Limited | 237.66 Million INR | -10823.963% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| Biofil Chemicals and Pharmaceuticals Limited | 20.65 Million INR | -125587.452% |
| Brooks Laboratories Limited | -72.25 Million INR | 36032.569% |
| Eris Lifesciences Limited | 5.18 Billion INR | -401.031% |
| FDC Limited | 3.03 Billion INR | -755.775% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | -189.135% |
| Gufic Biosciences Limited | 2.89 Billion INR | -797.158% |
| Hikal Limited | 1.49 Billion INR | -1637.518% |
| Ind-Swift Limited | 1.22 Billion INR | -2017.68% |
| Innova Captab Limited | 2.53 Billion INR | -924.785% |
| IOL Chemicals and Pharmaceuticals Limited | 4.94 Billion INR | -425.313% |
| Jagsonpal Pharmaceuticals Limited | 214.04 Million INR | -12029.509% |
| Jubilant Pharmova Limited | 5.18 Billion INR | -400.328% |
| Lincoln Pharmaceuticals Limited | 1.9 Billion INR | -1261.885% |
| Lupin Limited | 27.75 Billion INR | 6.471% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -94451.679% |
| Medico Remedies Limited | 277.11 Million INR | -9268.572% |
| Morepen Laboratories Limited | 4.17 Billion INR | -522.018% |
| Nectar Lifesciences Limited | 3.89 Billion INR | -567.302% |
| Orchid Pharma Limited | 2.36 Billion INR | -999.582% |
| Procter & Gamble Health Limited | 2.78 Billion INR | -831.874% |
| RPG Life Sciences Limited | 2.29 Billion INR | -1032.574% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -12378.731% |
| Sigachi Industries Limited | 1.47 Billion INR | -1661.454% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 773.83% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | -463.455% |
| Themis Medicare Limited | 1.3 Billion INR | -1892.318% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Vaishali Pharma Limited | 6.29 Million INR | -412388.084% |
| Wanbury Limited | 1.7 Billion INR | -1420.729% |
| Windlas Biotech Limited | 1.29 Billion INR | -1898.784% |
| ZIM Laboratories Limited | 1.09 Billion INR | -2264.238% |
| Ind-Swift Laboratories Limited | 2 Billion INR | -1192.263% |
| Ipca Laboratories Limited | 29.59 Billion INR | 12.28% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 75.109% |
| Venus Remedies Limited | 534.65 Million INR | -4755.878% |
| Sakar Healthcare Limited | 495.5 Million INR | -5139.493% |
| Aurobindo Pharma Limited | 104.5 Billion INR | 75.157% |
| Divi's Laboratories Limited | 18.31 Billion INR | -41.791% |
| AstraZeneca Pharma India Limited | 4.47 Billion INR | -480.299% |
| Mankind Pharma Limited | 40.86 Billion INR | 36.473% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Laurus Labs Limited | 3.94 Billion INR | -557.499% |
| Neuland Laboratories Limited | 5.31 Billion INR | -388.183% |
| J. B. Chemicals & Pharmaceuticals Limited | 7.54 Billion INR | -244.249% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | -299.269% |
| Zydus Lifesciences Limited | 45.39 Billion INR | 42.805% |
| Amrutanjan Health Care Limited | 621.02 Million INR | -4080.495% |
| Wockhardt Limited | 140 Million INR | -18444.286% |
| Bal Pharma Limited | 214.56 Million INR | -11999.604% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 61.668% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | -2009.015% |
| Par Drugs and Chemicals Limited | 551.58 Million INR | -4606.766% |
| Caplin Point Laboratories Limited | 7.22 Billion INR | -259.321% |
| Shilpa Medicare Limited | 3.76 Billion INR | -590.19% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| Ajanta Pharma Limited | 19.67 Billion INR | -31.939% |
| Aarey Drugs & Pharmaceuticals Limited | 2.83 Million INR | -917017.477% |
| Granules India Limited | 6.52 Billion INR | -297.686% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Syncom Formulations (India) Limited | 249.25 Million INR | -10316.006% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | -2.474% |
| Suven Life Sciences Limited | -1.22 Billion INR | 2217.926% |
| Krebs Biochemicals & Industries Limited | - INR | -Infinity% |
| Strides Pharma Science Limited | 5.22 Billion INR | -396.803% |
| Indoco Remedies Limited | 1.52 Billion INR | -1603.096% |
| Alpa Laboratories Limited | 61.51 Million INR | -42104.34% |
| Lasa Supergenerics Limited | -458 Million INR | 5768.497% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 730.905% |